In addition, Ladomersky et al. reported a robust increase in the expression of PD-L1 in older samples, indicating older patients with lymphoma, glioma and leukemia, may be less responsive to immunotherapy like ICB treatment42,43. The gene discussed is CD274; the disease is glioma.